Efficient macrophage isolation of human immunodeficiency virus from peripheral blood leukocytes from healthy seropositive individuals: implications for cell tropism. NLM AIDSLINE Important note: Information in this article was accurate in 1990. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Efficient macrophage isolation of human immunodeficiency virus from peripheral blood leukocytes from healthy seropositive individuals: implications for cell tropism.

Trans Assoc Am Physicians. 1989;102:110-6. Unique Identifier : AIDSLINE MED/90296508
Poli G; Massari FE; Schnittman SM; Psallidopoulos MC; Davey V; Lane HC; Fauci AS; Laboratory of Immunoregulation, National Institute of Allergy and; Infectious Diseases, National Institutes of Health, Bethesda,; Maryland 20892.


Abstract: We investigated the efficiency of HIV isolation from the PBL of 23 healthy, HIV-seropositive individuals with high (600-700/mm3) CD4+ T cell counts. Cocultivations of patients' PBL with allogeneic T lymphocyte blasts or monocytes were performed. T lymphocyte blasts allowed recovery of 4/23 (17%) HIV isolates, whereas monocytes allowed recovery of 12/23 (52%) isolates. Monocyte cultures sustained release of viral antigen for up to 70 days. Nine of the viral isolations could be accomplished only with this monocyte coculture technique. To determine the in vivo source of the macrophage-tropic HIV isolates we separated PBL from 5 of these 9 patients into T lymphocyte and monocyte fractions by cell sorting; then, we analyzed the fractions by PCR to amplify HIV proviral DNA. In 4 out of 5 patients studied HIV-1 proviral DNA was detected only in T lymphocytes but not in monocytes, although the virus was isolated exclusively by monocyte coculture technique. In the remaining patient, HIV DNA was found to be present in both T cells and monocytes. Thus, HIV can be more efficiently isolated in healthy seropositive individuals by coculture of their PBL with normal monocytes rather than T cell blasts. Of note, the most common in vivo source of viral isolates which preferentially infect monocytes in vitro (macrophage-tropic strains) is the circulating CD4+ T lymphocyte.
Keywords: Cells, Cultured Human HIV/*ISOLATION & PURIF HIV Seropositivity/*MICROBIOLOGY Leukocytes/MICROBIOLOGY Lymphocyte Transformation Macrophages/*MICROBIOLOGY Monocytes/MICROBIOLOGY Polymerase Chain Reaction T-Lymphocytes/IMMUNOLOGY/MICROBIOLOGY Viremia/*MICROBIOLOGY JOURNAL ARTICLEKWDcells,culturedhumanhiv/KWDisolation&purifhivseropositivity/KWDmicrobiologyleukocytes/microbiologylymphocytetransformationmacrophages/KWDmicrobiologymonocytes/microbiologypolymerasechainreactiont-lymphocytes/immunology/microbiologyviremia/KWDmicrobiologyjournalarticle
901030
M90A0661

Copyright © 1990 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1990. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1990. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .